![]() |
Ingevity Corporation (NGVT) Évaluation DCF
US | Basic Materials | Chemicals - Specialty | NYSE
|

- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Ingevity Corporation (NGVT) Bundle
Explorez l'avenir financier d'Ingevity Corporation (NGVT) avec notre calculatrice DCF conviviale! Entrez vos projections pour la croissance, les marges et les dépenses pour déterminer la valeur intrinsèque d'Ingevity Corporation (NGVT) et améliorer votre stratégie d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,216.1 | 1,391.5 | 1,668.3 | 1,692.1 | 1,406.4 | 1,472.7 | 1,542.1 | 1,614.8 | 1,691.0 | 1,770.7 |
Revenue Growth, % | 0 | 14.42 | 19.89 | 1.43 | -16.88 | 4.71 | 4.71 | 4.71 | 4.71 | 4.71 |
EBITDA | 397.8 | 337.2 | 456.3 | 224.6 | -329.5 | 218.4 | 228.7 | 239.4 | 250.7 | 262.6 |
EBITDA, % | 32.71 | 24.23 | 27.35 | 13.27 | -23.43 | 14.83 | 14.83 | 14.83 | 14.83 | 14.83 |
Depreciation | 118.2 | 127.2 | 124.9 | 122.8 | 108.3 | 121.7 | 127.4 | 133.4 | 139.7 | 146.3 |
Depreciation, % | 9.72 | 9.14 | 7.49 | 7.26 | 7.7 | 8.26 | 8.26 | 8.26 | 8.26 | 8.26 |
EBIT | 279.6 | 210.0 | 331.4 | 101.8 | -437.8 | 96.7 | 101.3 | 106.0 | 111.0 | 116.3 |
EBIT, % | 22.99 | 15.09 | 19.86 | 6.02 | -31.13 | 6.57 | 6.57 | 6.57 | 6.57 | 6.57 |
Total Cash | 257.7 | 275.4 | 76.7 | 95.9 | 68.0 | 165.2 | 173.0 | 181.1 | 189.7 | 198.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 166.7 | 167.0 | 249.3 | 211.0 | 141.0 | 186.0 | 194.8 | 203.9 | 213.6 | 223.6 |
Account Receivables, % | 13.71 | 12 | 14.94 | 12.47 | 10.03 | 12.63 | 12.63 | 12.63 | 12.63 | 12.63 |
Inventories | 189.0 | 241.2 | 335.0 | 308.8 | 226.8 | 257.2 | 269.4 | 282.1 | 295.3 | 309.3 |
Inventories, % | 15.54 | 17.33 | 20.08 | 18.25 | 16.13 | 17.47 | 17.47 | 17.47 | 17.47 | 17.47 |
Accounts Payable | 104.2 | 125.8 | 174.8 | 158.4 | 94.5 | 130.1 | 136.2 | 142.6 | 149.4 | 156.4 |
Accounts Payable, % | 8.57 | 9.04 | 10.48 | 9.36 | 6.72 | 8.83 | 8.83 | 8.83 | 8.83 | 8.83 |
Capital Expenditure | -105.9 | -103.8 | -142.5 | -109.8 | -77.6 | -108.1 | -113.2 | -118.6 | -124.2 | -130.0 |
Capital Expenditure, % | -8.71 | -7.46 | -8.54 | -6.49 | -5.52 | -7.34 | -7.34 | -7.34 | -7.34 | -7.34 |
Tax Rate, % | 19.66 | 19.66 | 19.66 | 19.66 | 19.66 | 19.66 | 19.66 | 19.66 | 19.66 | 19.66 |
EBITAT | 215.7 | 152.3 | 260.1 | 54.4 | -351.7 | 70.0 | 73.3 | 76.8 | 80.4 | 84.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -23.5 | 144.8 | 115.4 | 115.5 | -232.9 | 43.7 | 72.7 | 76.1 | 79.7 | 83.5 |
WACC, % | 8.77 | 8.63 | 8.81 | 8.05 | 8.87 | 8.63 | 8.63 | 8.63 | 8.63 | 8.63 |
PV UFCF | ||||||||||
SUM PV UFCF | 273.7 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 85 | |||||||||
Terminal Value | 1,285 | |||||||||
Present Terminal Value | 849 | |||||||||
Enterprise Value | 1,123 | |||||||||
Net Debt | 1,387 | |||||||||
Equity Value | -264 | |||||||||
Diluted Shares Outstanding, MM | 36 | |||||||||
Equity Value Per Share | -7.26 |
What You Will Receive
- Adjustable Forecast Parameters: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Comprehensive Data: Ingevity Corporation’s (NGVT) financial information pre-loaded to facilitate your analysis.
- Instant DCF Calculations: The model automatically computes Net Present Value (NPV) and intrinsic value for your convenience.
- Tailored and Professional Design: A refined Excel template that meets your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating forecasts, confirming strategies, and optimizing your time.
Key Features
- Accurate Ingevity Financials: Gain access to reliable pre-loaded historical data and future forecasts.
- Tailorable Forecast Assumptions: Modify highlighted cells such as WACC, growth rates, and profit margins.
- Automatic Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries for clear visualization of your valuation findings.
- Designed for All Users: An easy-to-navigate layout suitable for investors, CFOs, and consultants alike.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Ingevity Corporation's (NGVT) preloaded data.
- 2. Modify Key Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various forecasts to understand potential valuation results.
- 5. Present with Assurance: Share professional valuation analyses to back your strategic decisions.
Why Choose This Calculator for Ingevity Corporation (NGVT)?
- Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for Ingevity Corporation (NGVT).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Ingevity’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Ingevity Corporation (NGVT).
Who Should Use This Product?
- Investors: Evaluate Ingevity Corporation’s (NGVT) valuation before making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation strategies employed by established firms like Ingevity Corporation.
- Consultants: Provide comprehensive valuation analyses and reports for clients involving Ingevity Corporation.
- Students and Educators: Utilize real-time data to study and instruct on valuation practices related to Ingevity Corporation.
What the Template Contains
- Preloaded NGVT Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.